tradingkey.logo

Intuitive Surgical Inc

ISRG
504.620USD
-2.930-0.58%
交易中 美東報價延遲15分鐘
178.89B總市值
63.06本益比TTM

Intuitive Surgical Inc

504.620
-2.930-0.58%

關於 Intuitive Surgical Inc 公司

Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.

Intuitive Surgical Inc簡介

公司代碼ISRG
公司名稱Intuitive Surgical Inc
上市日期Jun 13, 2000
CEORosa (David J)
員工數量15638
證券類型Ordinary Share
年結日Jun 13
公司地址1020 Kifer Road
城市SUNNYVALE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94086
電話14085232100
網址https://www.intuitive.com/en-us/about-us/company
公司代碼ISRG
上市日期Jun 13, 2000
CEORosa (David J)

Intuitive Surgical Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1000.00%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
228.75K
-5454.00%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
26.16K
--
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
13.01K
+739.00%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
3.11K
+739.00%
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
3.00K
-4731.00%
Dr. Monica P. Reed, M.D.
Dr. Monica P. Reed, M.D.
Independent Director
Independent Director
2.35K
+739.00%
Ms. Sreelakshmi Kolli
Ms. Sreelakshmi Kolli
Independent Director
Independent Director
979.00
+739.00%
Mr. Mark Preston Brosius
Mr. Mark Preston Brosius
Senior Vice President, Chief Manufacturing and Supply Chain Officer
Senior Vice President, Chief Manufacturing and Supply Chain Officer
852.00
-1076.00%
Mr. Lewis Chew
Mr. Lewis Chew
Independent Director
Independent Director
783.00
+739.00%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1000.00%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
228.75K
-5454.00%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
26.16K
--
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
13.01K
+739.00%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
3.11K
+739.00%
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
3.00K
-4731.00%

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Instruments and accessories
1.52B
60.63%
Systems
590.40M
23.57%
Services
395.90M
15.80%
地區USD
名稱
營收
佔比
U.S.
1.72B
68.56%
Outside of United states
787.50M
31.44%
業務
地區
業務USD
名稱
營收
佔比
Instruments and accessories
1.52B
60.63%
Systems
590.40M
23.57%
Services
395.90M
15.80%

股東統計

更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
9.43%
BlackRock Institutional Trust Company, N.A.
5.33%
State Street Investment Management (US)
4.38%
T. Rowe Price Associates, Inc.
3.46%
Geode Capital Management, L.L.C.
2.33%
其他
75.05%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
9.43%
BlackRock Institutional Trust Company, N.A.
5.33%
State Street Investment Management (US)
4.38%
T. Rowe Price Associates, Inc.
3.46%
Geode Capital Management, L.L.C.
2.33%
其他
75.05%
股東類型
持股股東
佔比
Investment Advisor
49.26%
Investment Advisor/Hedge Fund
27.06%
Hedge Fund
3.07%
Research Firm
2.90%
Pension Fund
2.47%
Bank and Trust
2.40%
Sovereign Wealth Fund
1.44%
Individual Investor
0.51%
Family Office
0.32%
其他
10.58%

機構持股

更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
3647
313.93M
88.55%
-8.96M
2025Q3
3649
310.67M
87.63%
-11.36M
2025Q2
3621
320.38M
89.37%
-5.49M
2025Q1
3598
321.67M
89.74%
-4.21M
2024Q4
3426
322.11M
90.31%
-1.17M
2024Q3
3255
319.27M
89.84%
-8.25M
2024Q2
3152
322.86M
91.02%
+572.17K
2024Q1
3116
317.58M
89.60%
-829.16K
2023Q4
3055
314.33M
89.27%
-2.70M
2023Q3
2961
312.82M
89.02%
-3.61M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
33.43M
9.43%
+258.72K
+0.78%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
18.90M
5.33%
-196.41K
-1.03%
Sep 30, 2025
State Street Investment Management (US)
15.54M
4.38%
-12.88K
-0.08%
Sep 30, 2025
T. Rowe Price Associates, Inc.
12.28M
3.46%
-605.75K
-4.70%
Sep 30, 2025
Geode Capital Management, L.L.C.
8.27M
2.33%
+84.99K
+1.04%
Sep 30, 2025
Invesco Capital Management (QQQ Trust)
7.95M
2.24%
+438.98K
+5.84%
Dec 31, 2025
Capital World Investors
7.73M
2.18%
+116.03K
+1.52%
Sep 30, 2025
Fidelity Management & Research Company LLC
4.84M
1.36%
-3.59M
-42.62%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
4.73M
1.33%
+127.12K
+2.76%
Jun 30, 2025
AllianceBernstein L.P.
4.04M
1.14%
-153.40K
-3.66%
Sep 30, 2025
查看更多

持股ETF

更新時間: 10月2日 週四
更新時間: 10月2日 週四
機構名稱
佔比
Langar Global HealthTech ETF
14.08%
iShares U.S. Medical Devices ETF
13.62%
Simplify Health Care ETF
6.65%
First Trust Nasdaq Lux Digi Health Solutions ETF
6.58%
Global X Robotics & Artificial Intelligence ETF
6.53%
Invesco AI and Next Gen Software ETF
5%
Goldman Sachs Future Health Care Equity ETF
4.73%
iShares US Select Equity Active ETF
4.67%
Neuberger Berman Disrupters ETF
4.34%
Fidelity Digital Health ETF
3.66%
查看更多
Langar Global HealthTech ETF
佔比14.08%
iShares U.S. Medical Devices ETF
佔比13.62%
Simplify Health Care ETF
佔比6.65%
First Trust Nasdaq Lux Digi Health Solutions ETF
佔比6.58%
Global X Robotics & Artificial Intelligence ETF
佔比6.53%
Invesco AI and Next Gen Software ETF
佔比5%
Goldman Sachs Future Health Care Equity ETF
佔比4.73%
iShares US Select Equity Active ETF
佔比4.67%
Neuberger Berman Disrupters ETF
佔比4.34%
Fidelity Digital Health ETF
佔比3.66%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
Aug 05, 2021
Split
1→3
公告日期
除權除息日
類型
比率
Aug 05, 2021
Split
1→3
KeyAI